Note: Ingredients listed on restricted chemical lists
EC/CAS
69-65-8
Name of the chemical
D-mannitol C6H14O6
Concentration
N/A
General Information
Revision date
2010-10-04
Product name
Levact 2.5 mg/ml. 26mg and 60mg Vials
Icons in SDS
Company Information
company name
Napp Pharmaceuticals Group
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H351, H360
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
BENDAMUSTINE HYDROCHLORIDE
2.1 Classification of the substance or mixture
By EC1272/2008 By 999/45/EC, 67/548/EC
S-phrase(s)
Levact® Levact® 2.5 mg/ml. 26mg and 60mg Vials Medicinal Product Ribomustin® Napp Pharmaceuticals Group The Science Park Milton road Cambridge CB4 0AB Main reception: 01223 424444 Health,Safety & Environment Dept: 01223 424444 (08 30-16 30) Medical Information: 01223 424444 oncologymedinfo@napp.co.uk. CAS 3543-75-7 Acute Toxicity Oral: Cat 3 Carcinogenicity: Cat 2 Reprotoxicity: Cat1B
Signal word
Danger H301 Toxic if swallowed H351 Suspected of causing cancer H360 May damage fertility or the unborn child P201 Obtain special instructions before use P281 Use PPE as required P301+P310 If swallowed (call a poison centre or Doctor) P308+P313 If exposed get medical advice Harmful If swallowed, Xn Limited Evidence of carcinogenic effect May Impair fertility May cause Harm to the unborn child R60 May impair fertility R61 may cause harm to the unborn child R22 harmful if swallowed R40 Limited evidence of carcinogenic effects S36 wear suitable Protective clothing S37 Wear suitable Gloves Version 1.0
